STOCK TITAN

Leggett & Platt, Inc. (LEG) Financials

LEG
Trailing 12 months to June 30, 2026
Revenue $3.9B -8.1% YoY
Net Income $219.4M +54.2% YoY
EPS (Diluted) $1.56 +51.5% YoY
Free Cash Flow $156.9M -36.4% YoY
Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 6, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the LEG SEC filings page.

Leggett & Platt, Inc. (LEG) reported $3.9B in revenue over the twelve months to Jun 30, 2026, down 8.1% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI LEG FY2025

Leggett now operates on a smaller sales base, yet cash generation and balance-sheet leverage have improved.

In FY2024, a net loss of $511M coexisted with operating cash flow of $306M. In FY2025, net income returned to $235M while operating cash flow reached $338M, showing that reported earnings have been a noisier guide to cash generation than the cash-flow statement.

The business is operating on a smaller revenue base: revenue was $4.1B in FY2025 versus $5.1B in FY2021. Gross margin fell to 17.1% in FY2024, then recovered to 18.4% in FY2025; with sales still declining, that points to margin repair rather than growth-driven operating leverage.

Deleveraging is visible in the capital structure: debt-to-equity fell from 2.7x in FY2024 to 1.5x in FY2025, making the balance sheet less levered than a year earlier. Capital expenditures were $57.2M against operating cash flow of $338M, so most operating cash remained after the reported capital spend.

[ NOT FINANCIAL ADVICE ]

Financial Health Signals

Profitability Growth Leverage Liquidity CashFlow Returns 28 / 100
Financial Health Score 28/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Leggett & Platt, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability
0

Not available for Leggett & Platt, Inc., and counted as zero in the overall score.

Growth
12

Leggett & Platt, Inc.'s revenue declined 7.5% year-over-year, from $4.4B to $4.1B. This contraction results in a growth score of 12/100.

Leverage
38

Leggett & Platt, Inc. has a moderate D/E ratio of 1.46. This balance of debt and equity financing earns a leverage score of 38/100.

Liquidity
65

With a current ratio of 2.25, Leggett & Platt, Inc. holds $2.25 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 65/100.

Cash Flow
53

Leggett & Platt, Inc. has a free cash flow margin of 6.9%, earning a moderate score of 53/100. The company generates positive cash flow after capital investments, but with room for improvement.

Returns
0

Not available for Leggett & Platt, Inc., and counted as zero in the overall score.

Piotroski F-Score Strong
7/9

Leggett & Platt, Inc. passes 7 of 9 financial strength tests. All 4 profitability signals pass (positive income, cash flow, and earnings quality), 2 of 3 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality Cash-Backed
1.44x

For every $1 of reported earnings, Leggett & Platt, Inc. generates $1.44 in operating cash flow ($338.2M OCF vs $235.4M net income). This indicates profits are well-supported by actual cash generation, not accounting adjustments.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue
$999.7M
YoY-5.5%
QoQ+8.9%
5Y CAGR-4.9%
10Y CAGR-0.5%

Leggett & Platt, Inc. generated $999.7M in revenue in Q2 2026. This represents a decrease of 5.5% from the same quarter a year earlier. Against the prior quarter it is up 8.9%.

Net Income
$47.1M
YoY-10.3%
QoQ+135.5%
5Y CAGR-15.9%
10Y CAGR-9.0%

Leggett & Platt, Inc. reported $47.1M in net income in Q2 2026. This represents a decrease of 10.3% from the same quarter a year earlier. Against the prior quarter it is up 135.5%.

EPS (Diluted)
$0.33
YoY-13.2%
QoQ+135.7%
5Y CAGR-16.6%
10Y CAGR-9.2%

Leggett & Platt, Inc. earned $0.33 per diluted share (EPS) in Q2 2026. This represents a decrease of 13.2% from the same quarter a year earlier. Against the prior quarter it is up 135.7%.

EBITDA

Not reported for Q2 2026.

Cash & Balance Sheet

Free Cash Flow
$25.3M
YoY-66.5%
QoQ+131.5%
5Y CAGR+9.7%
10Y CAGR-14.5%

Leggett & Platt, Inc. generated $25.3M in free cash flow in Q2 2026, representing cash available after capex. This represents a decrease of 66.5% from the same quarter a year earlier. Against the prior quarter it is up 131.5%.

Cash & Debt
$545.8M
YoY+48.0%
QoQ+6.9%
5Y CAGR+18.7%
10Y CAGR+6.7%

Leggett & Platt, Inc. held $545.8M in cash against $1.5B in long-term debt as of Q2 2026.

Dividends Per Share
$0.05
YoY0.0%
QoQ0.0%
5Y CAGR-34.7%
10Y CAGR-17.4%

Leggett & Platt, Inc. paid $0.05 per share in dividends in Q2 2026. That is unchanged from the same quarter a year earlier. It is unchanged from the prior quarter.

Shares Outstanding
137M
YoY+0.9%
QoQ+0.1%
5Y CAGR+0.5%
10Y CAGR+0.2%

Leggett & Platt, Inc. had 137M shares outstanding in Q2 2026. This represents an increase of 0.9% from the same quarter a year earlier. Against the prior quarter it is up 0.1%.

Margins & Returns

Gross Margin
20.3%
YoY+2.1pp
QoQ+1.7pp
5Y change-0.6pp
10Y change-1.9pp

Leggett & Platt, Inc.'s gross margin was 20.3% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is up 2.1 percentage points from the same quarter a year earlier. Against the prior quarter it is up 1.7 percentage points.

Net Margin
4.7%
YoY-0.2pp
QoQ+2.5pp
5Y change-4.0pp
10Y change-6.8pp

Leggett & Platt, Inc.'s net profit margin was 4.7% in Q2 2026, showing the share of revenue converted to profit. This is down 0.2 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.5 percentage points.

Return on Equity
4.3%
YoY-1.8pp
QoQ+2.4pp
5Y change-3.0pp
10Y change-7.1pp

Leggett & Platt, Inc.'s ROE was 4.3% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 1.8 percentage points from the same quarter a year earlier. Against the prior quarter it is up 2.4 percentage points.

Operating Margin

Not reported for Q2 2026.

Capital Allocation

Share Buybacks
$300K
YoY0.0%
QoQ-91.2%
5Y CAGR-15.6%
10Y CAGR-40.8%

Leggett & Platt, Inc. spent $300K on share buybacks in Q2 2026, returning capital to shareholders by reducing shares outstanding. That is unchanged from the same quarter a year earlier. Against the prior quarter it is down 91.2%.

Capital Expenditures
$20.5M
YoY+141.2%
QoQ-15.6%
5Y CAGR-3.9%
10Y CAGR-3.8%

Leggett & Platt, Inc. invested $20.5M in capex in Q2 2026, funding long-term assets and infrastructure. This represents an increase of 141.2% from the same quarter a year earlier. Against the prior quarter it is down 15.6%.

R&D Spending

Not reported for Q2 2026.

LEG Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LEG quarterly income statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Revenue$999.7M-5.5%$918.2M-10.2%$938.6M-11.2%$1.0B-5.9%$1.1B-6.3%$1.0B-6.8%$1.1B-4.1%$1.1B-6.3%
Cost of Revenue$796.5M-8.0%$747.5M-10.2%$770.8M-12.5%$842.7M-6.5%$865.4M-8.1%$832.1M-8.6%$880.8M-3.8%$901.1M-6.2%
Gross Profit$203.2M+5.5%$170.7M-10.2%$167.8M-4.4%$193.7M-3.4%$192.6M+3.3%$190.0M+1.9%$175.6M-12.1%$200.6M-6.4%
SG&A Expenses$119.8M+1.2%$121.5M-1.7%$121.8M-2.1%$124.5M-2.0%$118.4M-10.0%$123.6M-1.8%$124.4M+2.7%$127.0M+16.4%
Interest Expense$14.7M-28.3%$14.5M-22.9%$15.1M-27.8%$18.5M-11.9%$20.5M-8.5%$18.8M-13.0%$20.9M-1.4%$21.0M-4.5%
Income Tax$21.3M+10.9%$11.9M-17.9%-$6.6M-161.1%$27.2M+112.5%$19.2M+159.6%$14.5M+34.3%$10.8M+112.1%$12.8M-28.9%
Net Income$47.1M-10.3%$20.0M-34.6%$25.2M+76.2%$127.1M+183.1%$52.5M+108.7%$30.6M-3.2%$14.3M+104.8%$44.9M-15.0%
EPS (Basic)$0.34-10.5%$0.14-36.4%$0.18+80.0%$0.92+178.8%$0.38+108.7%$0.22-4.3%$0.10+104.6%$0.33-15.4%
EPS (Diluted)$0.33-13.2%$0.14-36.4%$0.18+80.0%$0.91+175.8%$0.38+108.7%$0.22-4.3%$0.10+104.6%$0.33-15.4%
Diluted Shares (Avg)142M+1.4%141M+1.7%N/A140M+1.6%140M+1.7%139M+0.9%N/A138M+0.9%

Not reported in any period shown, so not listed: R&D Expenses, Operating Income, EBITDA.

LEG Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LEG quarterly balance sheet
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Total Assets$3.6B-2.7%$3.5B-6.1%$3.5B-3.4%$3.5B-6.7%$3.7B-3.5%$3.7B-18.8%$3.7B-21.0%$3.8B-25.6%
Current Assets$1.8B+5.1%$1.7B-2.1%$1.7B+3.1%$1.7B-1.5%$1.7B-2.6%$1.8B-4.1%$1.7B-10.1%$1.7B-8.0%
Cash & Equivalents$545.8M+48.0%$510.5M+23.7%$587.4M+67.7%$460.7M+66.2%$368.8M+20.1%$412.6M+14.2%$350.2M-4.2%$277.2M+1.2%
Short-Term Investments$0$0$0$0$0$0$0$0
Inventory$638.3M-1.6%$663.3M-2.2%$622.6M-13.8%$634.0M-16.0%$648.6M-14.1%$678.3M-16.0%$722.6M-11.8%$754.4M-9.6%
Accounts Receivable$518.4M-4.4%$487.1M-6.7%$433.7M-13.8%$536.1M-8.2%$542.2M-8.6%$522.3M-9.5%$503.0M-11.0%$583.9M-6.9%
Long-Term Investments$0$0$0$0$0$0$0$0
Goodwill$745.1M-0.8%$747.6M+1.7%$751.4M-5.4%$748.5M-8.1%$751.2M-6.6%$734.9M-50.4%$794.4M-46.7%$814.7M-44.8%
Total Liabilities$2.5B-11.5%$2.5B-17.4%$2.5B-15.4%$2.6B-16.0%$2.8B-10.2%$3.0B-9.7%$3.0B-10.0%$3.0B-11.7%
Current Liabilities$779.3M-2.9%$748.7M-7.6%$775.0M-8.4%$794.1M-32.2%$802.3M-31.3%$810.4M-31.8%$846.4M-33.0%$1.2B+16.1%
Non-Current Liabilities$1.7B-14.9%$1.7B-21.0%$1.7B-18.2%$1.8B-5.8%$2.0B+2.1%$2.2B+2.5%$2.1B+4.3%$1.9B-23.3%
Long-Term Debt$1.5B-16.5%$1.5B-22.7%$1.5B-19.7%$1.5B-5.2%$1.8B+5.3%$1.9B+9.1%$1.9B+10.9%$1.6B-19.6%
Total Equity$1.1B+26.5%$1.0B+39.2%$1.0B+48.3%$971.8M+31.1%$855.0M+28.1%$746.8M-42.1%$689.4M-48.3%$741.0M-54.7%
Retained Earnings$2.3B+9.0%$2.3B+9.4%$2.3B+10.1%$2.3B+9.6%$2.1B+5.7%$2.1B-20.6%$2.1B-22.4%$2.1B-31.9%

LEG Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LEG quarterly cash flow statement
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Operating Cash Flow$45.8M-45.5%-$56.1M-925.0%$121.5M-0.7%$125.9M+31.8%$84.0M-10.6%$6.8M+211.5%$122.3M-16.3%$95.5M-33.6%
Depreciation & Amortization$28.2M-4.1%$27.8M-10.9%$31.3M-7.4%$29.0M-20.3%$29.4M-9.8%$31.2M-5.2%$33.8M-24.6%$36.4M-19.1%
Stock-Based CompensationN/A$11.3M+37.8%N/AN/AN/A$8.2M-18.0%N/AN/A
Capital Expenditures$20.5M+141.2%$24.3M+82.7%$19.6M-10.1%$15.8M-14.1%$8.5M-45.2%$13.3M-48.6%$21.8M-6.8%$18.4M-17.1%
Free Cash Flow$25.3M-66.5%-$80.4M-1136.9%$101.9M+1.4%$110.1M+42.8%$75.5M-3.8%-$6.5M+79.7%$100.5M-18.1%$77.1M-36.6%
Investing Cash Flow-$8.3M-150.6%-$10.6M-73.8%$5.2M+129.2%$277.8M+139000.0%$16.4M+300.0%-$6.1M+41.3%-$17.8M-28.1%-$200K+98.6%
Financing Cash Flow-$6.4M+95.8%-$10.3M-117.2%-$6.5M+72.2%-$312.9M-141.6%-$153.8M-13.8%$60.0M+231.5%-$23.4M+51.2%-$129.5M-2.9%
Dividends Paid$6.8M0.0%$6.8M+1.5%$6.8M+3.0%$6.7M0.0%$6.8M-89.0%$6.7M-89.1%$6.6M-89.2%$6.7M-89.1%
Share Buybacks$300K0.0%$3.4M+70.0%$0-100.0%$100K-50.0%$300K+50.0%$2.0M-51.2%$400K-20.0%$200K0.0%

LEG Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

LEG quarterly financial ratios
MetricQ2'2610-QQ1'2610-QQ4'2510-QQ3'2510-QQ2'2510-QQ1'2510-QQ4'2410-KQ3'2410-Q
Gross Margin20.3%+2.1pp18.6%0.0pp17.9%+1.3pp18.7%+0.5pp18.2%+1.7pp18.6%+1.6pp16.6%-1.5pp18.2%0.0pp
Net Margin4.7%-0.2pp2.2%-0.8pp2.7%+1.3pp12.3%+8.2pp5.0%+58.3pp3.0%+0.1pp1.4%+28.3pp4.1%-0.4pp
Return on Equity4.3%-1.8pp1.9%-2.2pp2.5%+0.4pp13.1%+7.0pp6.1%+96.3pp4.1%+1.7pp2.1%+24.4pp6.1%+2.8pp
Return on Assets1.3%-0.1pp0.6%-0.3pp0.7%+0.3pp3.6%+2.4pp1.4%+17.1pp0.8%+0.1pp0.4%+6.8pp1.2%+0.2pp
Current Ratio2.35+0.2x2.33+0.1x2.25+0.3x2.15+0.7x2.17+0.6x2.20+0.6x2.00+0.5x1.48-0.4x
Debt-to-Equity1.38-0.7x1.44-1.2x1.46-1.2x1.54-0.6x2.10-0.5x2.59+1.2x2.70+1.4x2.13+0.9x
Asset Turnover0.280.0x0.260.0x0.270.0x0.290.0x0.290.0x0.270.0x0.29+0.1x0.29+0.1x
FCF Margin2.5%-4.6pp-8.8%-8.1pp10.9%+1.3pp10.6%+3.6pp7.1%+0.2pp-0.6%+2.3pp9.5%-1.6pp7.0%-3.3pp

Not reported in any period shown, so not listed: Operating Margin.

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company Fiscal year Revenue Net income Net margin Market cap Health score
Leggett & Platt, Inc. LEG FY2025 $4.1B $235.4M 5.8% $1.3B 28/100
La-Z-Boy Incorporated LZB FY2026 $2.1B $102.0M 4.8% $1.2B 52/100
MillerKnoll, Inc. MLKN FY2026 $3.8B $91.5M 2.4% $1.4B 40/100
MasterBrand, Inc. MBC FY2025 $2.7B $26.7M 1.0% $1.4B 46/100
Interface Inc TILE FY2025 $1.4B $116.1M 8.4% $2.1B 65/100
American Woodmark Corp AMWD FY2025 $1.7B $99.5M 5.8% $700.7M 47/100

Frequently Asked Questions

What is Leggett & Platt, Inc.'s annual revenue?

Leggett & Platt, Inc. (LEG) reported $4.1B in total revenue for fiscal year 2025. This represents a -7.5% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Leggett & Platt, Inc.'s revenue growing?

Leggett & Platt, Inc. (LEG) revenue declined by 7.5% year-over-year, from $4.4B to $4.1B in fiscal year 2025.

Is Leggett & Platt, Inc. profitable?

Yes, Leggett & Platt, Inc. (LEG) reported a net income of $235.4M in fiscal year 2025, with a net profit margin of 5.8%.

Leggett & Platt, Inc. (LEG) reported diluted earnings per share of $1.69 for fiscal year 2025. This represents a 145.3% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

As of fiscal year 2025, Leggett & Platt, Inc. (LEG) had $587.4M in cash and equivalents against $1.5B in long-term debt.

Leggett & Platt, Inc. (LEG) had a gross margin of 18.4% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

Leggett & Platt, Inc. (LEG) had a net profit margin of 5.8% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

Yes, Leggett & Platt, Inc. (LEG) paid $0.20 per share in dividends during fiscal year 2025.

Leggett & Platt, Inc. (LEG) has a return on equity of 23.0% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

Leggett & Platt, Inc. (LEG) generated $281.0M in free cash flow during fiscal year 2025. This represents a 25.4% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

Leggett & Platt, Inc. (LEG) generated $338.2M in operating cash flow during fiscal year 2025, representing cash generated from core business activities.

Leggett & Platt, Inc. (LEG) had $3.5B in total assets as of fiscal year 2025, including both current and long-term assets.

Leggett & Platt, Inc. (LEG) invested $57.2M in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

Yes, Leggett & Platt, Inc. (LEG) spent $2.4M on share buybacks during fiscal year 2025, returning capital to shareholders by reducing shares outstanding.

Leggett & Platt, Inc. (LEG) had 136M shares outstanding as of fiscal year 2025.

Leggett & Platt, Inc. (LEG) had a current ratio of 2.25 as of fiscal year 2025, which is generally considered healthy.

Leggett & Platt, Inc. (LEG) had a debt-to-equity ratio of 1.46 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

Leggett & Platt, Inc. (LEG) had a return on assets of 6.7% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

Leggett & Platt, Inc. (LEG) has a Piotroski F-Score of 7 out of 9, indicating strong financial health. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Leggett & Platt, Inc. (LEG) has an earnings quality ratio of 1.44x, considered cash-backed (high quality). This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Leggett & Platt, Inc. (LEG) scores 28 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.

Back to top